News - Page 204 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Post published:February 24, 2021
Post category:Press Release

Read more about the article NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial

Post published:February 24, 2021
Post category:Press Release

Read more about the article Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director

Post published:February 23, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of Units

Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of Units

Post published:February 23, 2021
Post category:Press Release

Read more about the article Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Post published:February 23, 2021
Post category:Press Release

Read more about the article PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic Pharmaceuticals

PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic Pharmaceuticals

Post published:February 23, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Inc. Announces Marketed Public Offering

Bright Minds Biosciences Inc. Announces Marketed Public Offering

Post published:February 22, 2021
Post category:Press Release

Read more about the article Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Post published:February 22, 2021
Post category:Press Release

Read more about the article Beckley Psytech appoints ex-pharma CEO as Chief Operating Officer

Beckley Psytech appoints ex-pharma CEO as Chief Operating Officer

Post published:February 22, 2021
Post category:Press Release

Read more about the article Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial

Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial

Post published:February 22, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.